Product Safety is a growing concern in the global pharmaceutical market, and the United States is no exception. To assure product safety and government compliance, Sunset Pharmaceuticals, Inc. follows the Prescription Drug Marketing Act, which states:
The Prescription Drug Marketing Act (PDMA) of 1987 (P.L. 100-293, 102 Stat. 95) is a law of the United States federal government. It establishes legal safeguards for prescription drug distribution to ensure safe and effective pharmaceuticals. It's designed to discourage the sale of counterfeit, adulterated, misbranded, sub potent, and expired prescription drugs. It was passed in response to the development of a wholesale sub-market (known as the "diversion market") for prescription drugs.
The PDMA was modified by the Prescription Drug Amendments of 1992 (P.L. 102-353, 106 Stat. 941) on August 26, 1992.
The U.S. Food and Drug Administration (FDA) issued regulations implementing the PDMA in 1990 (21 C.F.R. Part 205) and 1999 (21 C.F.R. Part 203).
Sunset Pharmaceuticals, Inc. is committed to the security and safety of the United States’ pharmaceutical supply chain. We purchase most branded and generic pharmaceuticals directly from the product manufacturers. All other product purchases are made through an Authorized Distributor of Record (ADR). Pedigree records are kept for all products that Sunset Pharmaceuticals, Inc. purchases and distributes.
To comply with Federal and State regulations, Sunset Pharmaceuticals, Inc. will only distribute pharmaceutical products to licensed healthcare professionals. Please fax or email a copy of your DEA certificate to Sunset Pharmaceuticals Inc. verifying your shipping address.